Pharmaceutical Groups Say Europe 2020 Strategy Must Focus on Fostering R&D, Clinical Trial Reforms

Drug Industry Daily
Drug industry groups are urging the European Commission to invest more in research and development, streamline regulatory systems and accelerate recently approved clinical trial reforms as ways to bolster the EU’s pharmaceutical industry.

To View This Article:


Subscribe To Drug Industry Daily